Brushing teeth during aplasia: safe or risky?
NCT ID NCT03879252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether brushing teeth is safe for patients with prolonged aplasia (low blood cell counts) after intensive chemotherapy. Currently, many hospitals only allow mouthwash to avoid bleeding and infection. The trial compared brushing with an extra-soft toothbrush plus mouthwash versus mouthwash alone in 76 patients. The goal was to see if brushing improves oral health without increasing risks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Toothbrush and mouthwash solution
- What this could lead to
- If successful, this could allow patients with aplasia to brush their teeth safely, improving comfort and well-being during hospital stays.
- What could go wrong
- This is a small, completed Phase 3 trial with 76 participants, so results may not apply to all patients. There is still a risk of bleeding or infection from brushing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
76 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
Feb 2023
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Hospitalized Patients in protected area of the Blood Disease Service with predictable prolonged aplasia and risk of mucite * Acute myeloblastic leukemia undergoing induction or consolidation treatment * Acute lymphoblastic leukemia under induction treatment * Patients affiliated or beneficiaries of a social security * Written inform consent Exclusion Criteria: * Patients with removable complete dentures * Constitutional disorder of coagulation * Hematopoietic stem cell allogreffe * Therapeutic intensification with autograft of haematopoietic stem cells * Patient unable to provide oral care alone (brushing teeth or mouthwash) * Already included in the study * Pregnant women, lactating mothers * Persons deprived of liberty by an administrative or judicial decision * Persons undergoing psychiatric care under duress * Adults who are subject to a legal or non-state protection measure to express their consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute lymphoblastic leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Angers
Angers, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells aim to wipe out stubborn leukemia
- Tweaking donor cells may shield older transplant patients from a dangerous complication
- The immune cells that could make stem cell transplants work better
- Aloe vera mouthwash tested against chemotherapy mouth sores
- Can a Chemo-Only prep beat radiation for childhood leukemia transplants?
- Can a targeted drug hit the mark in Hard-to-Treat blood cancers?